283 related articles for article (PubMed ID: 15205220)
1. Laminopathies and atherosclerosis.
Al-Shali KZ; Hegele RA
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1591-5. PubMed ID: 15205220
[TBL] [Abstract][Full Text] [Related]
2. Hutchinson-Gilford progeria syndrome.
Pollex RL; Hegele RA
Clin Genet; 2004 Nov; 66(5):375-81. PubMed ID: 15479179
[TBL] [Abstract][Full Text] [Related]
3. [The role of lamins and mutations of LMNA gene in physiological and premature aging].
Sliwińska MA
Postepy Biochem; 2007; 53(1):46-52. PubMed ID: 17718387
[TBL] [Abstract][Full Text] [Related]
4. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis.
Csoka AB; English SB; Simkevich CP; Ginzinger DG; Butte AJ; Schatten GP; Rothman FG; Sedivy JM
Aging Cell; 2004 Aug; 3(4):235-43. PubMed ID: 15268757
[TBL] [Abstract][Full Text] [Related]
5. Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature.
Mazereeuw-Hautier J; Wilson LC; Mohammed S; Smallwood D; Shackleton S; Atherton DJ; Harper JI
Br J Dermatol; 2007 Jun; 156(6):1308-14. PubMed ID: 17459035
[TBL] [Abstract][Full Text] [Related]
6. A progeroid syndrome in mice is caused by defects in A-type lamins.
Mounkes LC; Kozlov S; Hernandez L; Sullivan T; Stewart CL
Nature; 2003 May; 423(6937):298-301. PubMed ID: 12748643
[TBL] [Abstract][Full Text] [Related]
7. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
Denecke J; Brune T; Feldhaus T; Robenek H; Kranz C; Auchus RJ; Agarwal AK; Marquardt T
Hum Mutat; 2006 Jun; 27(6):524-31. PubMed ID: 16671095
[TBL] [Abstract][Full Text] [Related]
8. The laminopathies: a clinical review.
Rankin J; Ellard S
Clin Genet; 2006 Oct; 70(4):261-74. PubMed ID: 16965317
[TBL] [Abstract][Full Text] [Related]
9. Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction.
Bidault G; Garcia M; Vantyghem MC; Ducluzeau PH; Morichon R; Thiyagarajah K; Moritz S; Capeau J; Vigouroux C; Béréziat V
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2162-71. PubMed ID: 23846499
[TBL] [Abstract][Full Text] [Related]
10. LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset.
Kane MS; Lindsay ME; Judge DP; Barrowman J; Ap Rhys C; Simonson L; Dietz HC; Michaelis S
Am J Med Genet A; 2013 Jul; 161A(7):1599-611. PubMed ID: 23666920
[TBL] [Abstract][Full Text] [Related]
11. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
12. Targeted transgenic expression of the mutation causing Hutchinson-Gilford progeria syndrome leads to proliferative and degenerative epidermal disease.
Sagelius H; Rosengardten Y; Hanif M; Erdos MR; Rozell B; Collins FS; Eriksson M
J Cell Sci; 2008 Apr; 121(Pt 7):969-78. PubMed ID: 18334552
[TBL] [Abstract][Full Text] [Related]
13. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
14. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
[TBL] [Abstract][Full Text] [Related]
15. Reversible phenotype in a mouse model of Hutchinson-Gilford progeria syndrome.
Sagelius H; Rosengardten Y; Schmidt E; Sonnabend C; Rozell B; Eriksson M
J Med Genet; 2008 Dec; 45(12):794-801. PubMed ID: 18708427
[TBL] [Abstract][Full Text] [Related]
16. Disruption of spermatogenesis in mice lacking A-type lamins.
Alsheimer M; Liebe B; Sewell L; Stewart CL; Scherthan H; Benavente R
J Cell Sci; 2004 Mar; 117(Pt 7):1173-8. PubMed ID: 14996939
[TBL] [Abstract][Full Text] [Related]
17. Phenomics, lipodystrophy, and the metabolic syndrome.
Hegele RA
Trends Cardiovasc Med; 2004 May; 14(4):133-7. PubMed ID: 15177263
[TBL] [Abstract][Full Text] [Related]
18. LMNA mutations in progeroid syndromes.
Huang S; Kennedy BK; Oshima J
Novartis Found Symp; 2005; 264():197-202; discussion 202-7, 227-30. PubMed ID: 15773755
[TBL] [Abstract][Full Text] [Related]
19. Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: clues to the biology of premature atherosclerosis in Hutchinson-Gilford Progeria Syndrome.
Gordon LB; Harten IA; Patti ME; Lichtenstein AH
J Pediatr; 2005 Mar; 146(3):336-41. PubMed ID: 15756215
[TBL] [Abstract][Full Text] [Related]
20. The truncated prelamin A in Hutchinson-Gilford progeria syndrome alters segregation of A-type and B-type lamin homopolymers.
Delbarre E; Tramier M; Coppey-Moisan M; Gaillard C; Courvalin JC; Buendia B
Hum Mol Genet; 2006 Apr; 15(7):1113-22. PubMed ID: 16481358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]